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Abstract
Several human neurodegenerative disorders are characterized by the accumulation of 8-oxo-7,8-dihydroguanine (8-oxodG) in
the DNA of affected neurons. This can occur either through direct oxidation of DNA guanine or via incorporation of the
oxidized nucleotide during replication. Hydrolases that degrade oxidized purine nucleoside triphosphates normally minimize
this incorporation. hMTH1 is the major human hydrolase. It degrades both 8-oxodGTP and 8-oxoGTP to the corresponding
monophosphates. To investigate whether the incorporation of oxidized nucleic acid precursors contributes to
neurodegeneration, we constructed a transgenic mouse in which the human hMTH1 8-oxodGTPase is expressed. hMTH1
expression protected embryonic fibroblasts and mouse tissues against the effects of oxidants. Wild-type mice exposed to 3-
nitropropionic acid develop neuropathological and behavioural symptoms that resemble those of Huntington’s disease.
hMTH1 transgene expression conferred a dramatic protection against these Huntington’s disease–like symptoms, including
weight loss, dystonia and gait abnormalities, striatal degeneration, and death. In a complementary approach, an in vitro
genetic model for Huntington’s disease was also used. hMTH1 expression protected progenitor striatal cells containing an
expanded CAG repeat of the huntingtin gene from toxicity associated with expression of the mutant huntingtin. The findings
implicateoxidizednucleicacidprecursorsintheneuropathologicalfeaturesofHuntington’sdiseaseandidentifytheutilization
of oxidized nucleoside triphosphates by striatal cells as a significant contributor to the pathogenesis of this disorder.
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Introduction
Mammalian cells assign considerable resources to protecting
their DNA against mutagenic oxidative damage by the reactive
oxygen species (ROS) that are an inevitable by-product of
oxidative metabolism. An imbalance in the production and
detoxification of ROS can lead to a condition of oxidative stress
and the accumulation of DNA lesions. DNA 8-oxo-7,8-dihydro-
guanine (8-oxodG) is a marker of DNA oxidation and shares with
other oxidized bases the ability to miscode during replication to
generate base substitution mutations. The accumulation of DNA
8-oxodG is associated with genome instability and increased
cancer incidence [1,2].
Endogenous DNA damage caused by ROS is also considered to
be important in the etiology of several neurodegenerative
disorders. Recent evidence indicates that defects in the repair of
DNA damage produced by oxidative stress can lead to neuronal
cell death. Thus, rare neurodegenerative diseases such as ataxia
with oculomotor apraxia 1 (AOA1) or spinocerebellar ataxia with
axonal neuropathy 1 (SCAN1) are defective in genes (aprataxin
(APTX) and tyrosyl-DNA phosphodiesterase 1 (TDP1), respective-
ly) encoding enzymes involved in the repair of specific types of
DNA single strand breaks. It has been suggested that the
accumulation of oxidative stress-induced oxidative DNA damage
underlie the neurodegeneration in AOA1 and SCAN1 tissues [for
review, see [3]. In addition to these genetic diseases with DNA
repair defects, accumulation of oxidative damage in brain DNA is
often associated with other neurodegenerative diseases such as
Huntington’s disease (HD) [4–6], Parkinson’s disease (PD) [7] or
amyotrophic lateral sclerosis (ALS) [8–9].
What is the source of this oxidative DNA damage? DNA 8-
oxodG can derive from direct oxidation of DNA guanine in situ or
via incorporation from the oxidized dNTP pool during replication.
Mammalian cells have multiple repair mechanisms to protect their
genome against the accumulation of DNA 8-oxodG. The major
participants in this are the specific DNA glycosylases (OGG1,
MYH and NEILs) belonging to the base excision repair (BER)
pathway [10]. The nucleotide excision repair CSA and CSB
proteins also contribute [11–13].
The second layer of protection occurs at the level of nucleic
acid precursors. A family of hydrolases (NUDIX) eliminates
oxidized precursors from the dNTP pool, thereby excluding them
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the major human enzyme. It hydrolyzes three oxidized purine
deoxynucleoside triphosphates (8-oxodGTP, 2-OH-dATP and 8-
OH-dATP) to their corresponding monophosphates [15–16]. It
can also hydrolyze the ribo forms - 8-oxoGTP and 2-OH-ATP,
thereby preventing their incorporation into RNA [17,14]. The
phenotype of knockout mice confirms the importance of this
protection. Homozygous inactivation of the murine Mth1 gene
leads to elevated levels of DNA 8-oxodG and an increased
incidence of stomach, liver and lung cancer [18]. In addition,
inactivation of murine Mth1
2/2 in a PD model was associated
with the accumulation of excess oxidative DNA damage in
dopaminergic neurons following exposure to a selective neuro-
toxin [19].
To investigate this phenomenon in more detail, we took the
reverse approach and constructed transgenic mice expressing a
high level of the human MTH1 protein. In particular, we
investigated whether transgenic hMTH1 expression provided
protection against another neurodegenerative disorder, HD. HD
is a dominantly inherited disorder in which expansion of a CAG
repeat tract that lengthens a polyglutamine segment in the coding
region of the huntingtin (htt) gene to 37 or more residues, leads to
the progressive loss of neurons in the striatum [20]. Two
complementary approaches were employed. In the first, we used
an experimental model for HD in which 3-nitropropionic acid (3-
NP), an inhibitor of mitochondrial oxidative metabolism induces
oxidative stress and causes striatal degeneration and behavioural
deficits similar to those of HD [21]. In the second approach, we
examined the effect of hMTH1 in a genetic model of HD, in
which progenitor striatal cells from mutant knock-in mice express
the expanded CAG repeats in the htt gene [22]. Our findings
implicate oxidized nucleic acid precursors of striatal cells in the
neuropathological features of HD and identify them as significant
contributors to the development of this disease.
Results
Construction of a Transgenic Mouse Expressing the
hMTH1 cDNA
A 509 bp hMTH1 cDNA (BamH1-EcoRV fragment) [23] was
cloned into the gWIZ vector under the control of the CMV
promoter (Figure 1A) and an MscI-KpnI fragment microinjected
into pronuclei of zygotes. The presence of the transgene was
verified by Southern blotting of tail DNA from several founder
mice. This revealed a single integration site containing between 20
and 40 copies of the transgene (Figure 1B). One of the founder
mice expressing 40 copies of the hMTH1 transgene was selected
(Figure 1B, see arrow) and either maintained as hemizygous
(hMTH1-Tg
+/2) or bred to homozygousity (hMTH1-Tg
+/+). The
number of hMTH1 sites confirmed by FISH (Figure 1C). Crosses
between hMTH1 hemizygous produced offspring in the ratios
consistent with Mendelian segregation: 7/37 (18.9%) hMTH1-
Tg
+/+, 21/37 (56.7%) hMTH1-Tg
+/2 and 9/37 (24.3%)
hMTH1-Tg
2/2), (x
2 test; p#0,05).
We next examined hMTH1 expression in the animal tissues.
Transgene expression in several organs was first verified by RT-
PCR using human-specific primers (Figure 1D). Several organs
(brain, lung, liver, spleen, kidney, small intestine, ovary) expressed
hMTH1 at significant levels and western blotting of tissue extracts
confirmed the presence of the enzyme. No signal for the
endogenous mMTH1 protein was detected using the anti-human
hMTH1 antibody (data not shown and Figure 2A). hMTH1 was
particularly highly expressed in brain and kidney (Figure 1E).
hMTH1 Expression Protects MEFs against Oxidative
Damage In Vitro
Embryonic fibroblasts (MEFs) were prepared from hMTH1-
Tg
+/+ and wild-type animals and hMTH1 expression confirmed by
western blotting. When the total homogenate was immunoblotted
with anti-hMTH1, the antibody reacted with a single 18 KDa
protein of the expected size (Figure 2A, left panel). The
endogenous mouse MTH1 (mMTH1) was not detected by this
antibody raised against the human protein, possibly because of its
lower affinity for the mouse homolog [24]. We note that the levels
of hMTH1 protein in extracts of hMTH1-Tg
+/+ MEFs were
similar to those observed in some transformed human cell lines
(SV40-transformed MRC5 cells and SHSY5S neuroblastoma cell
line). It has been previously shown that the sequence encoded by
the hMTH1 cDNA has full information for the localization of the
protein in mitochondria as well as in the cytoplasm [23]. To
determine the intracellular localization of hMTH1 in hMTH1-
Tg
+/+ MEFs, cells were separated into cytosolic and mitochondrial
fractions and each subcellular fraction was analyzed by immuno-
blotting using the anti-hMTH1. Similarly to previous observations
in HeLa cells [23], hMTH1 was present in both fractions
indicating that the protein localizes also in mitochondria
(Figure 2A, right panel).
The steady-state levels of DNA 8-oxodG in wild-type and
transgenic MEFs were then examined. Transgene expression
reduced DNA 8-oxodG content 1.7 fold, from 0.4260.07 lesions
per 10
6 dG in wild-type cells, to 0.2560.02 in hMTH1-Tg
+/+ MEFs
(p-value=0.005, t-test)(Figure 2B, left panel). hMTH1 also
hydrolyzes oxidized ribonucleoside triphosphates to prevent their
utilization during RNA synthesis [14]. To examine whether
hMTH1 expression affected endogenous levels of RNA oxidation,
total RNA was extracted from wild-type and hMTH1-Tg
+/+ MEFs
using a protocol which allowed the simultaneous determination of
both the ribo- and deoxyribonucleosides of 8-oxoG by HPLC/EC
[25]. In wild-type MEFs steady-state levels of RNA 8-oxoG were
Author Summary
The oxidized purine 8-oxo-7,8-dihydroguanine (8-oxodG) is
often found at high levels in DNA of post-mortem brains of
patients afflicted by Huntington’s disease (HD) and other
neurodegenerative conditions. It has been unclear, how-
ever, whether this damage accumulation is a consequence
or a cause of neurodegeneration. We have addressed this
problem in a transgenic mouse model in which the human
hMTH1 8-oxodGTPase, which hydrolyzes oxidized nucleo-
side triphosphates to prevent the incorporation of
oxidized bases into nucleic acids, was expressed in several
organs. We report that high-level hMTH1 expression in the
transgenic mouse brain provides robust protection against
neurodegeneration as well as HD-like behavioural and
neuropathological symptoms in a chemical model of HD
(the mitochondrial toxin 3-nitropropionic acid). In a
complementary approach, we used a genetic model for
HD based on the use of progenitor striatal cells containing
an expanded CAG repeat of the huntingtin gene. Also, in
this case, hMTH1 provided strong protection against cell
death associated with expression of the mutant huntingtin
protein. The new findings we report shed important light
on the connection between oxidative DNA damage and
human neurodegenerative disorders. Our findings go
some way towards forging a causative link between
neurodegeneration and oxidative DNA/RNA damage and
identify the oxidized purine nucleoside triphosphates as
important contributors.
hMTH1 and HD-Like Neurodegeneration
PLoS Genetics | www.plosgenetics.org 2 November 2008 | Volume 4 | Issue 11 | e1000266Figure 1. Construction and characterization of a transgenic mouse expressing the hMTH1 cDNA. (A) A BamH1-EcoRV fragment (509 bp)
derived from pcDEBD [23] encoding the hMTH1 cDNA was subcloned into the gWIZ vector under the control of the CMV promoter. This vector
transfected into wild-type MEFs expressed the hMTH1 protein (data not shown). The MscI-KpnI fragment (2481 bp) was used in the construction of
the transgenic mouse. (B) Determination of transgene copy number. Genomic DNA from mouse tails was analysed by Southern blot analysis (left
panel). In the right panel 2, 5, 10, 20, 40 copies of the MscI-KpnI fragment were analysed. Both blots were probed with the same probe. Copy number
was determined by comparison. The arrow indicates the DNA from the mouse that was used as a founder for the colony. (C) Analysis by FISH of the
number of hMTH1 integrations in hemizygous (hMTH1-Tg
+/2) and homozygous (hMTH1-Tg
+/+) strains. (D) Expression of hMTH1 mRNA. RT-PCR was
performed using total RNA from the indicated organs and human specific primers. RT-PCR for the GADPH gene is used as an internal control. hMTH1
and GAPDH fragments are respectively 200 bp and 330 bp. (E) Western blot analysis of transgene expression. Total proteins (20–40 mg) from a range
of tissues were separated by SDS polyacrylamide electrophoresis, blotted and probed with an antibody against hMTH1. b-tubulin was used as a
loading control.
doi:10.1371/journal.pgen.1000266.g001
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PLoS Genetics | www.plosgenetics.org 3 November 2008 | Volume 4 | Issue 11 | e1000266Figure 2. hMTH1 protein in hMTH1-Tg
+/+ MEFs and protection against oxidative stress. (A) Expression of hMTH1 in wild-type and
homozygous hMTH1-Tg
+/+ MEFs. Total cell extracts were separated by 12%-SDS polyacrylamide electrophoresis, blotted and probed with an antibody
against hMTH1 [23]. The human SHSY5S neuroblastoma and SV40-transformed MRC5 cell lines are shown for comparison (left panel). Western
blotting of subcellular fractions of hMTH1-Tg
+/+ MEFs with anti-hMTH1 (right panel). Proteins were separated on 18%-SDS polyacrylamide
electrophoresis and cytocrome c was used to quantify mitocondrial cell extracts. (B) Steady-state levels of oxidized guanine. DNA and RNA from wild-
type (filled bars) and hMTH1-Tg
+/+ (open bars) MEFs were digested to nucleosides and 8-oxodG and 8-oxoG were separated and quantified by HPLC-
EC. Values are expressed as ratio to DNA and RNA guanine, respectively. Values are the mean6SE of 3 independent determinations. Asterisks indicate
statistically significant differences (p-value=0.005 and 0.015 for DNA and RNA, respectively; t-test). (C) Levels of oxidized guanine following oxidant
treatment. 8-oxodG and 8-oxoG were measured by HPLC-EC in DNA and RNA extracted from MEFs exposed to 40 mM KBrO3 for 30 min (time 0) and
after the indicated times of repair incubation in drug-free medium (30, 60, 120 min). Wild type (filled bars) and hMTH1-Tg
+/+ (open bars). Values are
the mean6SE of 3 independent determinations. Asterisks indicate a p-value#0.05; t-test.
doi:10.1371/journal.pgen.1000266.g002
hMTH1 and HD-Like Neurodegeneration
PLoS Genetics | www.plosgenetics.org 4 November 2008 | Volume 4 | Issue 11 | e100026625-fold higher than DNA 8-oxodG (the values were 10.3 8-oxoG
per 10
6 G in RNA versus 0.4 per 10
6 dG in DNA) (Figure 2B, right
panel) [26]. hMTH1 expression in untreated transgenic MEFs was
associated with a 2-fold decrease of RNA 8-oxoG compared with
wild-typecells(from10.3to5.5adductsper10
6 G; p=0.015,t-test).
This protection was also evident following exposure to an
exogenous oxidant. We chose KBrO3 since this chemical induces
very high levels of base damage [27] in comparison to other agents
which induce a more general type of oxidative stress, including
single and double strand breaks. In wild-type cells exposure for
30 min to 40 mM KBrO3 introduced into DNA 2.960.32 lesions
per 10
6 dG and this level of oxidation decreased over time with an
half life around 60 min (Figure 2C, left panel). In hMTH1-Tg
+/+
cells, initial DNA 8-oxodG levels were lower and the differences
were maintained during subsequent incubation (p-value,0.05, t-
test). We conclude that hMTH1 expression significantly reduces
the level of DNA 8-oxodG generated both endogenously and
following exposure to an exogenous oxidant.
KBrO3 treatment increased also RNA oxidation in wild-type
cells (Figure 2C, right panel). While 8-oxodG was efficiently
removed from DNA, levels of RNA 8-oxoG remained unchanged
at least for the initial 2 hrs post-treatment time. In contrast a
general trend towards decreased levels of oxidized RNA was
observed in hMTH1-expressing cells (Figure 2C). We conclude
that hMTH1 expression in hMTH1-Tg
+/+ MEFs protects against
endogenous and exogenous oxidation in both DNA and RNA.
hMTH1 also protected cells against DNA damage and killing
by an exogenous oxidant. Cytotoxicity assays indicated that
hMTH1-Tg
+/+ MEFs were strikingly more resistant than wild-type
MEFs to killing by a range of KBrO3 concentrations (Figure 3).
These data indicate that hMTH1 is a powerful barrier against cell
death induced by an oxidative stress.
Protective Effect of hMTH1 Expression against In Vivo
Oxidative Stress
To investigate whether hMTH1 also conferred protection
against oxidative DNA damage in the intact animal, oxidative
stress was induced in wild-type and transgenic mice by treatment
with paraquat. This pesticide is considered a model for oxidant-
induced toxicity by stimulating formation of superoxide radicals
[28–29]. Thus, paraquat-treated rats accumulate oxidative DNA
damage in several tissues, including brain, lung, heart, liver and
kidney [30]. Animals were treated i.p with multiple 10 mg/kg
paraquat doses (a total of 5 injections every other day over 10
days). Although no specific behavioural evaluations were per-
formed mice were indistinguishable from controls displaying no
overt signs of toxicity or gross behavioural alterations. Paraquat
produced high levels of DNA 8-oxodG in brain, heart, small
intestine and bone marrow of wild–type animals (Figure 4A and
4B). Expression of hMTH1 in the transgenic mice conferred a
significant protection against paraquat-induced oxidative DNA
damage and DNA 8-oxodG levels in these organs were between 4-
fold (small intestine and heart) and 9-fold (brain) lower in hMTH1-
Tg
+/+ than in wild-type animals (p=0.04, p=0.03 and p=0.01,
respectively, Student’s t-test) (Figure 4A).
The transgene also provided protection against endogenous
oxidation and steady-state levels of DNA 8-oxodG in brain, heart
and small intestine of untreated hMTH1-Tg
+/+ mice were 3.4-, 3.9-,
and 3.2- fold lower than in the same tissues of wild-type animals (p
values were 0.02, 0.01 and 0.01, respectively, Student’s t-test)
(Figure 4B). Thus reduced levels of 8-oxodG pools are likely to be
Figure 3. KBrO3 sensitivity of hMTH1-Tg
+/+ and wild-type MEFs.
Wild-type (closed symbols) and hMTH1-Tg
+/+ (open symbols) MEFs were
treated with KBrO3 for 30 min at the indicated concentrations. Viability
was measured by MTT assay 48 hr later. The graphs are the mean6SD
of 3 independent experiments.
doi:10.1371/journal.pgen.1000266.g003
Figure 4. Paraquat-induced DNA 8-oxodG in wild-type and
hMTH1-Tg
+/+ mice. (A) Groups of mice (n=13) were injected 5 times
every other day with 10 mg/kg paraquat per injection. DNA from the
indicated organs was digested and levels of 8-oxodG were determined
by HPLC-EC. Wild-type (filled bars); hMTH1-Tg
+/+ (open bars). Significant
differences (Student’s t-test) between wild-type and hMTH1-Tg
+/+
organs are shown with an asterisk. The p values were 0.01, 0.03 and
0.04 for brain, heart and small intestine, respectively. SI, small intestine.
BM, bone marrow. Values are the mean6standard errors. (B) Groups of
control mice (n=10) that had received saline injections on the same
schedule of Paraquat-treated animals were sacrificed 2 days after the
final injection. DNA 8-oxodG was determined in various organs as
described above. Wild-type (filled bars) and hMTH1-Tg
+/+ (open bars).
The p values (Student’s t-test) were 0.02, 0.01 and 0.01 for brain, heart
and small intestine, respectively. Values are the mean6standard errors.
doi:10.1371/journal.pgen.1000266.g004
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synthesis of endogenously incurred damage.
These findings indicate that mMTH1 activity is normally
limiting in several mouse tissues, including brain. The protection
conferred by hMTH1 indicates further that oxidized deoxynucleo-
side triphosphates are an important source of endogenous
oxidative DNA damage.
Protection by hMTH1 against HD-Like
Neurodegeneration Induced by 3-NP
To examine the effect of hMTH1 expression on HD-like
neurodegeneration, age-matched (8–10 weeks) transgenic and
wild-type animals were treated with the mitochondrial toxin 3-NP
(60 mg/kg i.p. twice a day for 5 days). This inhibitor of succinate
dehydrogenase selectively causes the death of striatal neurons and
induces symptoms similar to HD [21]. These include progressive
weight loss, neurological abnormalities such as foot and limb
dystonia, and, ultimately death.
Expression of hMTH1 in the transgenic animals protected
against 3-NP-induced neurodegeneration. The first evidence of
this protective effect was a significantly attenuated weight loss at
day 5 of treatment in hMTH1-Tg
+/+ mice (Figure 5A). In wild-type
animals, treatment with 3-NP causes a dramatic motor impair-
ment as shown by their high (.3) mean neurological score
(Figure 5B). Neurological score was defined as the highest score
reached at any time of the observation period according to the
following scale (modified from [31]): intermittent dystonia of one
hindlimb: 1; intermittent dystonia of two hindlimbs: 2; permanent
dystonia of hindimbs: 3; uncoordinated and wobbling gait or
recumbency: 3; near death recumbency: 4. Transgene expression
provided protection against this impairment and scores were
progressively lower in hMTH1 hemizygous and hMTH1 homo-
zygous mice (Figure 5B). hMTH1 activity was also associated with
a striking decrease of mortality. While at 5 days 55% (11/20) of
wild-type mice had died, the great majority of hMTH1-Tg
+/2 (13/
16) or hMTH1-Tg
+/+ (13/16) remained alive (Figure 5C). Post-
mortem examination of 3-NP-treated mice revealed detectable
striatal lesions (namely macroscopically-evident pale striatal areas)
in 77.7% of wild-type animals. These lesions were present in only
38.4% and 30% of hMTH1-Tg
+/2 and hMTH1-Tg
+/+ animals,
respectively (Figure 5D). In animals showing detectable striatal
lesion, a reduction in the mean lesion area was found in hMTH1-
Tg
+/+ (35156305 m
2,P ,0.05 vs wild type) and hMTH1-Tg
+/2
(41526511 m
2, NS) vs wild type mice (52626528 m
2). Further-
more, the rostrocaudal extension of the lesions was significantly
reduced in both hMTH1-Tg
+/2 and hMTH1-Tg
+/+ versus WT
mice (Figure 5E). Thus, hMTH1 expression significantly protects
the animals from the behavioural and neuropathological effects of
3-NP.
While basal levels of DNA 8-oxodG in untreated animals were
undetectable by immunohistochemical analysis of the oxidized
purine, a 5-day exposure to 3-NP increased the level of this
oxidized purine in the striatum and parietal and frontal cortex of
wild-type mice (Figure 6). This indicates that this mitochondrial
toxin produces extensive oxidative DNA damage.
Although endogenous mMTH1 is normally undetectable, it can
be visualized by immunofluorescence in the striatum of wild-type
mice following 3-NP-treatment (Figure 7A). This suggests that the
murine protein is induced in oxidatively stressed striatal cells. As
expected, a progressively increasing signal for hMTH1 was
observed in hemizygous hMTH1-Tg
+/2 and homozygous
hMTH1-Tg
+/+ animals (Figure 7A). hMTH1 expression signifi-
cantly reduced 8-oxodG levels in the major target area, the
striatum, and increasing protection was observed in hemizygous
hMTH1-Tg
+/2 and homozygous hMTH1-Tg
+/+ animals
(Figure 7B).
These data establish an inverse correlation between the levels of
DNA 8-oxodG and expression of the hMTH1 in the brain and
suggest that, during the course of chemically induced neurode-
generation, a large fraction of this oxidative lesion derives from an
oxidized dNTP pool.
It is possible therefore that the reduced levels of 8-oxodG pools
afforded by the hMTH1 transgene, resulted in a diminished
incorporation of 8-oxoG into DNA during repair of 3-NP induced
oxidative DNA damage.
Exogenous Expression of hMTH1 Protects Neural
Progenitor Cells Expressing the huntingtin Gene against
Cell Death
3-NP is a chemical model for HD-like striatal degeneration. We
also investigated whether hMTH1 also conferred protection in a
genetic model for HD. In this case the genetic alteration in the htt
gene had already occurred and the contribution of oxidized
precursors to the phenotype associated with an expanded CAG
tract was studied. We used neuronal progenitor cell lines
established from striatal primordia of wild-type or mutant htt
knockin mice (Hdh
Q7/Q7 and Hdh
Q111/Q111, respectively) in which
the htt gene CAG repeat length is normal or expanded [22]. These
nestin-positive cells have been immortalized with the tsA58 mutant
of SV40 large T antigen and at the non-permissive temperature
(39uC), similarly to the ST14A rat model [32], they cease
proliferation and withdraw from the cell cycle.
The vector expressing the hMTH1 cDNA (pcDEBD) [23] was
introduced into these cells by transfection and single clones with
similar levels of hMTH1 expression were isolated (Figure 8A). A
strong signal for hMTH1 was observed by immunofluorescence
both in the nuclei and cytoplasm of the transfectants, while a weak
hMTH1 signal in untransfected htt knockin cells showed mostly a
nuclear localization. In Figure 8B is shown an example for a
transfectant of the Hdh
Q111/Q111 cell line.
As previously reported [33], proliferating Hdh
Q111/Q111 striatal
cells expressing mutant htt are more sensitive than Hdh
Q7/Q7 cells to
killing by 3-NP as measured by LDH release (Figure 8C).
Expression of hMTH1 protected Hdh
Q111/Q111 cells against 3-NP
(p=0.02;Anovatest),buthad nosignificanteffectincellsexpressing
a wild-type htt gene (Figure 8C). Similar differences were revealed
when survival was measured by clonal assays (Figure 8D).
To investigate whether hMTH1 was able to protect mammalian
cells from toxicity associated with mutant htt expression even in the
absence of DNA synthesis, cell cultures were shifted at the non-
permissive temperature (39uC) to obtain a quiescent cell
population. FACS analysis demonstrated that degradation of the
mutant SV40 large T antigen led to a proliferative block in both
Hdh
Q7/Q7 and Hdh
Q111/Q111 cells (data not shown). Expression of
the mutated htt gene in Hdh
Q111/Q111 cells was associated with a
dramatic time-dependent increase in cell killing, while a large
percentage of normal Hdh
Q7/Q7 cells remained alive (Figure 8E). In
these culture conditions expression of hMTH1 provided again a
significant level of protection to Hdh
Q111/Q111 cells against cell
death (Figure 8E). Growth at 33uC was unaffected by expression of
hMTH1 in either Hdh
Q7/Q7 or Hdh
Q111/Q111 cells (data not shown).
From these results we conclude that hMTH1 is a major
protective factor against cell death caused by a mutant htt gene
both in proliferating and in quiescent cell culture conditions.
These results also indicate that oxidized precursors modulated by
hMTH1 plays a role in the phenotypic expression of striatal cell
toxicity similar to that occurring in HD.
hMTH1 and HD-Like Neurodegeneration
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The accumulation of oxidative damage in brain DNA is a
common feature of several neurodegenerative diseases [5–7],
although evidence for a causal contribution of these DNA lesions
to the disease process has been lacking. Our experiments with the
transgenic mouse expressing the human 8-oxo-dGTPase hMTH1
indicate that oxidized dNTPs are important contributors to basal
levels of DNA oxidation in vivo. In addition sanitization of the
oxidized pool by hMTH1 significantly lowers DNA 8-oxoG levels
in several tissues of mice exposed to the in vivo oxidant paraquat.
This broad-spectrum pesticide exerts its toxic effects in several
organs including lung, heart, liver, kidney and brain [28].
Although the mechanism of its toxicity is not fully elucidated,
paraquat has been shown to induce toxicity by stimulating oxygen
utilization via redox cycling and generating reactive oxygen
intermediates [34]. Thus, detection of increased DNA 8-oxodG in
paraquat-treated rats identified brain, lung, heart, liver and kidney
as target organs of paraquat-induced oxidative DNA damage [30].
We also observed accumulation of DNA 8-oxodG in several
Figure 5. 3-NP-induced toxicity in wild-type and hMTH1-Tg
+/2 and hMTH1-Tg
+/+ transgenic mice. Groups of wild-type (n=20), hMTH1-
Tg
+/2 (n=16) and hMTH1-Tg
+/+ (n=16) mice were injected i.p. twice daily for 5 days with 60 mg/kg 3-NP. Wild-type (black bars), hMTH1-Tg
+/2 (grey
bars) and hMTH1-Tg
+/+ (white bars). (A) Weight loss. Body weight, measured immediately before the first injection on the indicated days, is expressed
as a percentage of the pretreated body weight. (B) Motor impairment. Mice were monitored twice a day for dystonia and/or gait abnormalities.
Neurological score was as follows: intermittent dystonia of one hindlimb: 1; intermittent dystonia of two hindlimbs: 2; permanent dystonia of
hindimbs: 3; uncoordinated and wobbling gait or recumbency: 3; near death recumbency: 4. For each animal, the highest neurological score reached
at any time of the observation period was considered. Values are mean6standard errors. (C) Cumulative mortality. The non-surviving fraction at the
end of 5-day treatment is expressed as a percentage of starting total. (D) Striatal lesion formation. The percentage of animals with detectable post-
mortem striatal lesions is shown. (E) Size of striatal lesions. Postmortem measurements of striatal lesions along the rostrocaudal axis. The asterisks
indicate a P,0.05 vs wild-type according to One-way Anova and Tukey multiple comparison post-hoc test for panels A, B and E and to x
2 test for
panels C and D.
doi:10.1371/journal.pgen.1000266.g005
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paraquat. It is striking that protection provided by hMTH1
overexpression against paraquat-induced DNA damage occurred
in the same organs (brain, heart and small intestine) protected
against endogenous oxidation. This indicates that oxidized dNTPs
in these organs are a particularly important target for both
exogenous and endogenous sources of DNA damage. Thus,
hMTH1 represents a general mechanism of defence against
accumulation of oxidized purines in nucleic acids produced either
endogenously or by an exogenous oxidative stress.
Our in vitro observations using MEFs derived from hMTH1-Tg
mice support this conclusion and indicate that expression of
hMTH1 leads also to protection against cell death induced by an
in vitro exposure to an oxidant.
Experiments with knockout Mth1
2/2 mice established a
connection between mMTH1 activity and the levels of DNA
and RNA 8-oxodG in dopaminergic neurons following exposure
to a selective neurotoxin in a PD model [19] and in hippocampal
microglia during kainate-induced excitotoxicity [35]. In those
animals, abrogation of mMTH1 expression had no measurable
impact on the disease, however.
In contrast, transgenic hMTH1 expression revealed important
connections between nucleotide pool oxidation, HD-like neuro-
logical degeneration in a targeted area of the brain, and
neurological symptoms. Neurological symptoms that resemble
HD were produced in vivo by treating animals with 3-NP, an
inhibitor of complex II of the mitochondrial respiratory chain.
hMTH1 expression protects against HD-like neurodegeneration in
vivo and this is associated with decreased levels of DNA 8-oxodG
in the striatum. The dramatic attenuation of HD symptoms in
transgenic animals was reflected in a significantly reduced size of
the chemically–induced striatal lesions as well as in an increased
survival. Since hMTH1 protects against the accumulation of both
8-oxodG and 2-hydroxyadenine in nucleic acids [16], our findings
suggest that oxidized purine nucleotide precursors of DNA and
RNA might be causal factors in HD-like neurodegeneration.
Striatal neurodegeneration in 3-NP experimental model of HD
most likely occurs in terminally differentiated, non-dividing
neurons. Thus any impact of hMTH1 on nuclear DNA replication
is unlikely to be significant. Mitochondrial DNA stability is a
plausible alternative since impaired mitochondrial respiration and
ATP production play a central role in HD [36]. High levels of
hMTH1 in MEFs derived from the transgenic mice are localized
in the mitochondria, in agreement with previous reports in human
cells [23]. Intense staining for 8-oxodG in several areas of the
brain of wild type mice was produced by the 5-days exposure to 3-
NP. It is interesting that in a mouse model for PD induced by
systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydro-
pyridine, MTH1-null mice accumulated higher levels of 8-oxodG
in mitochondrial DNA of the striatum than wild-type mice and
this triggered neuronal dysfunction [19]. It is possible that a large
fraction of oxidative damage induced by 3-NP and identified by
immunostaining also resides in mitochondrial DNA. We suggest
that the protective role played by hMTH1 in this experimental
model of HD is, in all probability, a defensive mechanism against
mitochondrial degeneration induced by the neurotoxin.
The accumulation of 8-oxodG in neurodegerative diseases such
as PD, AD or ALS is paradoxically accompanied by up-regulation
of repair enzymes involved in the control of oxidative DNA
damage. Thus, increased levels of hMTH1 [37], hMYH [38], or
the mitochondrial form of hOGG1 [39] have been reported in the
mitochondria of neurons from substantia nigra of PD patients. This
up-regulation of several DNA repair enzymes has been interpreted
as a general marker of oxidative stress associated with this disease.
We observed increased immunostaining for mMTH1 in the
affected areas of the brain of wild-type mice induced by 3-NP to
show HD-like neurodegeneration. This suggests that in this
experimental model of HD, similarly to other neurodegenerative
diseases, increased levels of 8-oxodG are accompanied by an up-
regulation of MTH1 expression.
hMTH1 also protected neurons in a genetic model of HD, in
which progenitor striatal cells express an expanded CAG region of
the mouse htt gene. The role of oxidized purines in HD is probably
multifaceted and OGG1 can contribute to expansion of triplets in
the htt gene. Thus ablation of Ogg1 in R6/1 mice, a model of HD
which harbours a transgene containing exon 1 of the human HD
gene with an expanded CAG repeat, impairs age-dependent triplet
expansion [40]. In the model cell lines we used, CAG expansion in
the htt gene has already occurred, however. We show here that low
levels of 8-oxoG in nucleic acids provided by hMTH1 overex-
pression leads to protection against mutant htt-associated toxicity.
Thus proliferating progenitor striatal cells are protected against
Figure 6. Oxidative DNA damage in the brain. Brains from wild-type mice that had been treated twice per day for 5 days with 60 mg/kg 3-NP
were examined for DNA 8-oxodG by immunohistochemistry. Nuclei of striatum, parietal and frontal cortex were counterstained by DAPI.
doi:10.1371/journal.pgen.1000266.g006
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untreated wild-type mice (top panel, left) or 3-NP-treated (60 mg/kg twice daily for 5 days) wild-type, hMTH1-Tg
+/2, and hMTH1-Tg
+/+ animals. Nuclei
of striatum counterstained by DAPI are shown in the right panels. (B) 8-oxodG immunoreactivity in the striatum of 3-NP-treated wild-type, hMTH1-
Tg
+/2, and hMTH1-Tg
+/+ animals. Nuclei of striatum counterstained by DAPI are shown in the bottom panels.
doi:10.1371/journal.pgen.1000266.g007
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PLoS Genetics | www.plosgenetics.org 9 November 2008 | Volume 4 | Issue 11 | e1000266Figure 8. Sensitivity to 3-NP of striatal cells expressing hMTH1 and wild-type or mutant murine htt. Striatal cells derived from wild-type
Hdh
Q7/Q7 and mutant Hdh
Q111/Q111 mice were transfected with hMTH1. (A) Proteins were separated and probed with an antibody against hMTH1. (B)
Intracellular localization of hMTH1 (green fluorescence) in Hdh
Q111/Q111 and Hdh
Q111/Q111+hMTH1. Nuclei were counterstained by DAPI. (C) LDH
release. LDH release from striatal cells into culture medium was measured 24 hr after continuous exposure to 20 mM 3-NP. Hdh
Q7/Q7 (grey bar) and
Hdh
Q7/Q7+hMTH1 (dashed bar); Hdh
Q111/Q111 (black bars) and Hdh
Q111/Q111+hMTH1 (open bar). Mean6SE, n=4. (D) Clonal survival. Cloning efficiency
was determined at 33uC after 24 hr continuous exposure to the indicated 3-NP concentrations. Mean6SD, n=2. (E) Coulter counter assay. Survival of
non-proliferating cells measured in a Coulter Counter. Mean6SD, n=3. The asterisks indicate significant differences by Student’s t-test (p
values=0.02) between Hdh
Q111/Q111 and Hdh
Q111/Q111+hMTH1.
doi:10.1371/journal.pgen.1000266.g008
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chondrial toxin [33]. It has been shown that this is due to a non-
apoptotic form of cell death caused by mitochondrial membrane
depolarization [33]. In addition, mutant htt is also toxic to
quiescent cultures without exogenous stress, possibly because of
activation of specific apoptotic pathways [33]. hMTH1 expression
provided a safeguard effect in both settings suggesting that
oxidized triphosphates play a major role in both killing
mechanisms. This indicates that the oxidative DNA damage
modulated by hMTH1 can be not only causative for HD-like
disease (3-NP model) but may affect some phenotypic manifesta-
tions of this neurodegenerative disease. To address the possible
pathogenetic role of oxidative DNA damage in HD, a more
stringent experimental approach (e.g. cross breeding hMTH1
overexpressing mice with HD mice) is also planned. This will be
informative on the possible role of DNA 8-oxodG levels in
controlling the degree of triplet expansions as well as on the
progression of the disease.
Finally, the efficient hMTH1-mediated elimination of oxidized
RNA precursors we show here might be particularly important in
protecting vulnerable neuronal populations against translational
errors following mRNA oxidation [41]. This second function of
hMTH1 in preventing transcriptional errors [42,43] might play a
minor role in the dramatic neurotoxicity associated with an acute
exposure to 3-NP-induced oxidative stress. In human HD,
however, in which neurodegeneration requires a long period of
time to occur and neuronal populations are probably exposed to a
less dramatic level of oxidative insults, hMTH1 might become a
major safeguarding mechanism.
Materials and Methods
Construction of Transgenic Mice and Analysis of
Mendelian Ratio
The construct used to build the transgenic mice was obtained
using a BamH1-EcoRV fragment (509 bp) derived from pcDEBD
[23] encoding the hMTH1 cDNA and subcloned into the gWIZ
vector (Gene Therapy systems) under the control of the CMV
promoter. The MscI-KpnI fragment (2481 bp) was purified and
used for pronuclear injection of (C57/Bl66DBA2) F2 zygotes
using standard procedures. Injected embryos were implanted into
pseudopregnant (C57/Bl66DBA2) F1 foster mothers to complete
their development. All mice were genotyped by PCR using DNA
isolated from tail tips following standard proteinase K digestion
and phenol/chloroform extraction. The forward primer was
located in the vector (59-TCTTTTCTGCAGTCACCGT-39)
and the reverse primer in the hMTH1 cDNA (59-
GGTCTCTCCTTCTTGCAC-39). The 200 bp amplification
product was obtained by 1 cycle at 95uC for 5 min, 30 cycles of
95uC for 1 min, 57uC for 2 min and 72uC for 2 min, followed by 1
cycle of 72uC for 10 min. To assess the transgene copy number,
9 mg of MscI-KpnI DNA fragment was spiked with various
amounts equivalent to 1 (4.1 pg), 2, 5, 10, 20, 40 copies. DNA
(10 mg) from tail tips was digested with BamHI overnight at 37uC
and applied to electrophoresis on 0.8% agarose gel and transferred
onto Hybond N
+ nylon membrane (Amersham) by a standard
alkali transfer method. The filter was hybridized with the MscI-
KpnI fragment of hMTH1 cDNA labeled with [a-
32P]dCTP using
a labeling kit according to manufacturer’s instructions (Random
primed DNA labeling kit; Roche). Quantification was performed
using a phosphorImager (Canberra Pakard).
Five couple of hemizygous mice for hMTH1 were crossed to
analyse the Mendelian segregation and the offspring analysed by
FISH for the presence of transgene.
Fish Analysis
Further confirmations of the genotypic constitution of transgenic
mice were obtained by Fluorescent In Situ Hybridisation (FISH)
analysis. Fixed metaphases of bone marrow cells, extracted from
femurs of mice intraperitoneally injected 2 hrs before sacrifice with
4 mg/kg b.w. of Colchicine, were denaturated 2 min at 72uCi n
70% formamide and then hybridised overnight with 200 ng/mlo f
hMTH1 digoxigenated probe preparated by DIG-Nick translation
mix (Roche) according to manufacturer’s instructions. After
washing with 50% formamide at 37uC the probe was detected by
sheep anti-digoxigenin-rhodamineantibodiesandthe chromosomes
were counterstained by DAPI. Ten complete (40 chromosomes)
metaphases were analysed for each mouse.
Expression of hMTH1
RNA was isolated from indicated organs using the RNeasy Mini
kit following the manifacturer’s instruction (Quiagen). The RNA
pellet was briefly air-dried, resuspended in RNase-free water and
stored at 280uC. The RNA was retro-transcribed into cDNA by
using the SuperScript One-step RT-PCR with platinum Taq
(Invitrogen). Total RNA (500 ng) was used for the amplification
following the manufacturer’s instructions. In order to evaluate
hMTH1 expression, primers were designed to specifically allow the
detection of the human transcript without pairing with the mouse
one. The forward and reverse primers were respectively 59-
AGGAGAGCGGTCTGACA-39 and 59- GGCCACATGTCCTT-
GAAG-39. PCR conditions in the amplification were 55uCf o r
30 min and 94uC for 2 min, 35 cycles of 94uCf o r1m i n ,5 4 uCf o r
2m i n ,7 2 uC for 2 min. The final extension step was 10 min at 72uC.
PCR products were analysed on a 2% agarose gel. We used as
internal control the amplification of the mouse Gapdh (forward 59-
ATCCACTGGTGCTGCCAA-39 and reverse 59-CCACCCT-
GTTGCTGTAG-39).
Western Blot Analysis of hMTH1 in Organs and Cell
Extracts
Animals were killed by cervical dislocation and organs were
collected on ice. To prepare cell extracts 30 mg of each organ was
minced in USA buffer (1 ml) [Tris-Hcl 50 mM (pH 7.4), NaCl
250 mM, EDTA 5 mM (pH 8), 0.1% Triton, NaF 50 mM, NaOVa
0.1 mM and a protease inhibitor cocktail tablets (Complete mini,
Roche) by using a Mixer Mill 300 homogenizer. To prepare cell
extracts from MEFs, 10
6 cells were lysed in Ripa Buffer [Tris-Hcl
50 mM (pH 7.4), NaCl 150 mM, EDTA 1 mM (pH 8), 1% NP40,
NaF 1 mM, and a protease inhibitor cocktail tablets (Complete mini,
Roche)] for 1 hr on ice and then centrifuged at 14,000 rpm for
30 min. Cytosol and mitochondrial cell extracts were prepared using
the Mitochondria isolation kit (Pierce) according to manufacturer’s
instructions. Mitochondria were lysed in Ripa Buffer to obtain
mitochondrial protein fraction. Protein concentration was evaluated
using the Bradford method and 20–40 mg of total extract was
separated on 12%- (for whole cell extracts) and 18%- (for
mitochondrial and cytosolic fractions) -SDS polyacrylamide gels,
transferred to nitrocellulose membranes (Whatmann) with a
TransBlot cell apparatus (Bio-Rad), and probed overnight at 4uC
with anti-hMTH1 antibody [23] followed by the appropriate
secondary antibody. ECL detection reagents (Invitrogen) were used
to develop the blots. Loading controls for whole cell extract were b-
tubulin(1:5000) and cytochrome c(1:500)formitochondrialfractions.
Preparation of Mouse Embryo Fibroblasts and Cell
Cultures
MEFs were prepared from embryos derived from wild type or
hMTH1-Tg
+/+ pregnant females sacrificed after 13 days of
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embryos were rinsed in PBS, minced with scissors and the tissue
suspension was incubated in a solution of 0.25% (w/v) trypsin/
1 mM EDTA at 37u for 10 to 15 min with vigorous stirring. Then
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal bovine serum, penicillin (100 U/ml), and streptomycin
(100 mg/ml) (complete medium) was added and large clumps were
allowed to settle for 2 min. The decanted cells were centrifuged at
200 g for 5 min at room temperature and resuspended in
complete medium. MEFs spontaneously immortalised upon in
vitro passaging and were grown routinely in complete medium at
37uC in a 5% CO2 atmosphere (90% nominal humidity).
MTT Assays
Four thousand cells/well were plated in 96-well plates, treated
the next day with various concentration of KBrO3 (5–40 mM;
Sigma) in PBS/Hepes (20 mM) for 30 minutes at 37uC, washed in
PBS 16 and incubated in DMEM for 48 hrs. The 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) (MTT)
(Sigma) solution (20 ml, 5 mg/ml in PBS) was then added and
plates were incubated for 3 hr at 37uC. Following addition of 1
volume of DMSO, plates were incubated for 30 min in the dark.
The solubilized formazan was quantified at 570 nm, using a
microplate reader (DINEX, UK).
Analysis of 8-oxodG and 8-oxoG
Nucleic acids were isolated as previously described [25] with
minor modifications. Briefly, cells were trypsinized and cell pellets
lysed in 3 M guanidinium thiocyanate/10 mM deferoxamine
mesylate (DFOM). Cell lysates were transferred to Phase Lock gel
tubes, mixed with an equal volume of Phenol-Chloroform-Isoamyl
alcohol pH 6.7 and centrifuged. The acqueous phase containing
both DNA and RNA was extracted with one volume of
Chloroform-Isoamyl alcohol and precipitated with cold isopropa-
nol at 280uC. Nucleic acids were centrifuged, washed with cold
70% ethanol and air dried. For 8-oxodG and 8-oxoG determi-
nations pellets were dissolved in 30 mM DFOM solutions and
digested with 2–4 units Nuclease P1 and 10 units alkaline
phosphatase at 50uC for 1 hr. Samples were prepurified through
micropure EZ filters and transferred to HPLC autosampler vials.
Separation of digested DNA components was accomplished with a
Beckman System Gold HPLC apparate equipped with diode array
UV detection. Normal nucleosides were detected at 254 and
290 nm. Electrochemical detection of 8-oxoG and 8-oxo-dG was
performed with an ESA Coulochem II detector. Guard,
conditioning and 5011 high sensitive analytical cell were in line
with graphite filter elements. The whole system featured PEEK
tubings. Solvent system consisted of 5% MeOH and 95% 50 mM
potassium phosphate. Flow rate was 0.5 ml/min. The LC-18-DB
(Supelco, 7564.6 mm) analytical column was equipped with a
YMC ODS-AM 12 nm 5 mm guard column. The Beckman’s
Karat analytical software was used for data analysis.
In Vivo Treatments with Paraquat
Animals were kept under standardized temperature, humidity,
and lighting conditions with free access to water and food. Animal
care and use followed the directives of the Council of the EC (86/
609/EEC). Two groups (wild-type and hMTH1-Tg) of 8-weeks
old animals were treated with 10 mg/kg paraquat CL tetrahy-
drate. Animals of both sexes (1:1 ratio) were included in each
group. Mice were intraperitoneally injected with either saline or
Paraquat at 2-days intervals for a total of 5 doses. Animals were
killed by cervical dislocation 2 days after the end of treatment and
excised organs were washed with ice-cold PBS. Washed tissues
were snap-frozen in liquid nitrogen and thawed tissues were finely
minced in lysis buffer [10 mM Tris HCl (pH 8.0), 10 mM EDTA,
10 mM NaCl, and 0.5%SDS]. DNA was extracted by a high-salt
protein precipitation method. Briefly, following lysis tissues were
digested with RNase at 37uC for 1 hr and protease (Qiagen) at
37uC overnight. Proteins were precipitated by adding NaCl to
1.5 M, and DNA in the supernatant was collected by addition of 2
volume of ethanol. 8-oxodG was measured by HPLC with
electrochemical detection HPLC/EC as described previously [24].
In Vivo Treatment with 3-NP
3-NP (Sigma-Aldrich) was dissolved in PBS (pH adjusted with
NaOH) and administered twice a day (h 9.00 and 16.00) for 5 days
at the dose of 60 mg/kg i.p. Wild-type (20), hMTH1-Tg
+/2 (16)
and hMTH1-Tg
+/+ (16) mice were used. Animals of both sexes
(1:1 ratio) were included in each group. Baseline body weight was
determined before the start of the experiment. Weight changes
were monitored daily, immediately before the 9.00 injection. The
occurrence of dystonia and/or gait abnormalities was evaluated
twice a day. For each animal, the highest score reached at any
time of the observation period was considered, according to the
following scale: intermittent dystonia of one hindlimb: 1;
intermittent dystonia of two hindlimbs: 2; permanent dystonia of
hindimbs: 3; uncoordinated and wobbling gait or recumbency: 3;
near death recumbency: 4 (modified from ref. [31]). Two hours
after the last injection, surviving animals were killed by
decapitation; brains were removed and immediately frozen. For
each brain, serial 20-mm coronal sections were cut on a cryostat
microtome, stained with Cresyl violet and examined by light
microscopy. In animals showing a striatal lesion, the rostrocaudal
extension of the lesion and lesion areas were measured in mm and
m
2, respectively.
Immunofluorescence
Untreated and 3-NP-treated animals were killed by decapitation
and the brains were removed immediately and cryopreserved in
isopentane chilled on dry ice. Tissue was cut in 20 mM thin
section, these were placed on Superfrost/Plus microscope glass
slides and used for localization of 8-oxodG (anti-8-oxo-dG;
Trevigen) and hMTH1. To reveal 8-oxodG, slides prepared were
dried overnight at room temperature and fixed for 10 min in 70%
ethanol at 220uC then washed in PBS 16 and incubated in a
RNase solution (10 mM Tris-HCl (pH 7.5) 1 mM EDTA,
0.4 mM NaCl, 100 mg/mlRNase) for 1 hr at 37uC. To detect
the 8-oxodG in nuclear DNA slides were further denatured in
4NHCl for 7 minutes, blocked in 10% fetal bovine serum for 1 hr
at 37uC and incubated overnight at 4uC with anti-8-oxodG
monoclonal antibody [1:300 in 10 mM Tris-HCl (pH 7.5) 10%
serum]. On day 2 the slides were rinsed 2610 min in PBS 16
containing 0.025% triton X-100 and incubated with a TRITC
secondary antibody (goat anti-mouse) in serum 3% for 1 hr a 37uC
and nuclear staining was obtained with 200 mg/ml DAPI. To
reveal hMTH1, slides were dried overnight at room temperature,
fixed in absolute methanol at 220uC for 15 min and in ice-
acetone for 30 sec, then dried and frozen. Slides were then rinsed
3 times for 10 min each in PBS 16containing 0.025% triton X-
100 and incubated overnight at 4uC in a humidified chamber with
the primary human anti-MTH1 polyclonal antibody diluited
1:200 in 3% serum. Slides were then rinsed 3 times for 10 min in
PBS 16 containing 0.025% triton X-100 and incubated with a
secondary FITC antibody (goat anti-rabbit 488) in serum 3% for
1h ra3 7 uC and nuclear staining was obtained with 200 mg/ml
DAPI. Slides were mounted with Antifade and analyzed using a
Leica DMRB fluorescence microscope equipped with a CCD
hMTH1 and HD-Like Neurodegeneration
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System software.
Striatal Cell Cultures, DNA Transfection, and
Measurements of Cell Death
Cells derived from wild-type and mutant htt knockin mice
(Hdh
Q7/Q7 and Hdh
Q111/Q111) (a kind gift of Elena Cattaneo,
University of Milan) were routinely grown at 33uC in high-glucose
DMEM supplemented with 10% fetal bovine serum, penicillin
(100 U/ml), and streptomycin (100 mg/ml) (complete medium).
Exponentially growing Hdh
Q7/Q7 and Hdh
Q111/Q111 cells were
transfected (Lipofectamine) with pcDEBD and stable Hygromycin
(200–300 mg/ml) resistant clones were isolated after approximate-
ly 20 days in selective media. Survival after treatment with 3-NP
was determined by lactate dehydrogenase (LDH) release and
clonogenic assay. For LDH release, cells were plated in 48 well
plates in complete medium and incubated at 33uC. Serum-free
DMEM was added 24 hr later and cultures were exposed to 3-NP
for the next 24 hr. LDH release into the medium was evaluated
using a citotoxicity detection kit (Roche). Briefly,100 ml of medium
was mixed with 100 ml of the LDH substrate mixture in a 96 well
plate. After a 30 min incubation at room temperature the
absorbance was measured using a spectrophotometer. Results
are expressed as fold increase versus control and represent
means6standard error of at least 4 independent experiments,
assayed in triplicates. Statistical analysis was carried out by the
unpaired t-test and a p value,0.05 was considered significant. For
clonal assays, 100–200 cells were treated with the drug 18 hr after
seeding, cultures were washed 24 hr later, fed with complete
medium and 1–2 weeks later surviving colonies were fixed, stained
with Giemsa and counted.
To obtain a non-proliferating cell population, cultures were first
incubated at 33uC for 8 hr in complete medium. Before
transferring the cultures at 39uC complete medium was replaced
by serum-deprived medium (F-12/DMEM, 5 mg/l insulin,
100 mg/l transferrin, 20 nM progesterone, 30 nM selenite,
60 mM putrescine, 2 mM glutamine. 0.11 g/l sodium pyruvate,
3.7 g/l sodium bicarbonate and 3.9 g/l HEPES)[30]. To measure
survival, cells were trypsinized, resuspended in PBS and counted
using a Coulter Counter machine (ZM, Coulter Instruments).
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